Benefits and challenges with diagnosing chronic and late acute GVHD in children using the NIH consensus criteriaGeoff D.E. Cuvelier, Kirk R. Schultz, Eneida R. Nemecek et al.|Blood|2019Cited by 89
Immune profile differences between chronic GVHD and late acute GVHD: results of the ABLE/PBMTC 1202 studiesKirk R. Schultz, Geoff D.E. Cuvelier, Amina Kariminia et al.|Blood|2020Cited by 67
AluY-mediated germline deletion, duplication and somatic stem cell reversion in<i>UBE2T</i>defines a new subtype of Fanconi anemiaElizabeth L. Virts, Helmut Hanenberg, Anna Jankowska et al.|Human Molecular Genetics|2015Cited by 66
Outcomes of Measurable Residual Disease in Pediatric Acute Myeloid Leukemia before and after Hematopoietic Stem Cell Transplant: Validation of Difference from Normal Flow Cytometry with Chimerism Studies and Wilms Tumor 1 Gene ExpressionDavid A. Jacobsohn, Michael A. Pulsipher, Michael R. Loken et al.|Transplantation and Cellular Therapy|2018Cited by 44
A diagnostic classifier for pediatric chronic graft-versus-host disease: results of the ABLE/PBMTC 1202 studyGeoff D.E. Cuvelier, Kirk R. Schultz, Bernard Ng et al.|Blood Advances|2022Cited by 26